PDCD1 and neoplasm: Another study showed that tumors treated with neoadjuvant PD-1 immune checkpoint blockade contained higher numbers of CD3+ T cells, with further analysis of the T cell receptor repertoire showing that signatures from peripheral and tumor-infiltrating T cells overlapped, suggesting that T cells from the circulation infiltrated these gliomas (62).